Congress targets drug-equipment supply chains with 20-year felonies
H.R. 7184 — PRESS Act · Filed by Addison McDowell (R-NC) · 32 cosponsors · Introduced Jan 21, 2026 · Markup held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The PRESS Act makes it illegal to manufacture or distribute drug-production equipment (tableting machines, presses, capsule-filling machines, etc.) or precursor chemicals if you know or reasonably suspect they will be used to make controlled substances that will be smuggled into the U.S. The bill adds criminal penalties of 8–20 years imprisonment depending on the violation type and quantity involved, and directs the U.S. Sentencing Commission to update federal sentencing guidelines accordingly.
Why we flagged it
The bill's operative mechanism is criminal prohibition and sentencing enhancement for the manufacture and distribution of drug-production equipment and precursor chemicals destined for illegal importation. It is a straightforward narcotics-enforcement measure, not a regulatory carve-out or subsidy.
What the text implies
- The 'reasonable cause to believe' standard for criminal liability is subjective and may expose equipment manufacturers, chemical suppliers, and distributors to prosecution even absent direct knowledge of end use, potentially chilling legitimate commerce in dual-use items.
- Extraterritorial jurisdiction language (Section 1009 amendment) may enable prosecution of foreign nationals and entities with minimal U.S. nexus, raising questions about enforcement capacity and international cooperation.
The full analysis lists 3 implications of this text.
Who it affects
The bill targets the supply chain for illegal drug manufacturing equipment and precursors, aiming to disrupt fentanyl and other synthetic drug production before it reaches U.S. markets.